Display Settings:

Format
Items per page

Send to:

Choose Destination

Results: 17

1.

Osteosarcoma

A malignant neoplasm usually arising from bone. [from NCI]

MedGen UID:
10501
Concept ID:
C0029463
Neoplastic Process
2.

Osteosarcoma

A malignant bone tumor that usually develops during adolescence and usually affects the long bones including the tibia, femur, and humerus. The typical symptoms of osteosarcoma comprise bone pain, fracture, limitation of motion, and tenderness or swelling at the site of the tumor. [from HPO]

MedGen UID:
505326
Concept ID:
CN002426
Finding
3.

Neoplasm

A general term for autonomous tissue growth in which the malignancy status has not been established and for which the transformed cell type has not been specifically identified. [from NCI]

MedGen UID:
10294
Concept ID:
C0027651
Neoplastic Process
4.

Recurrent disease

The return of a disease after a period of remission. [from NCI]

MedGen UID:
78824
Concept ID:
C0277556
Disease or Syndrome
5.

Sarcoma

Your soft tissues connect, support, or surround other tissues. Examples include your muscles, tendons, fat, and blood vessels. Soft tissue sarcoma is a cancer of these soft tissues. There are many kinds, based on the type of tissue they started in. They may cause a lump or swelling in the soft tissue. Sometimes they spread and can press on nerves and organs, causing problems such as pain or trouble breathing. No one knows exactly what causes these cancers. They are not common, but you have a higher risk if you have been exposed to certain chemicals, have had radiation therapy, or have certain genetic diseases. Doctors diagnose soft tissue sarcomas with a biopsy. Treatments include surgery to remove the tumor, radiation therapy, chemotherapy, or a combination. NIH: National Cancer Institute.  [from MedlinePlus]

MedGen UID:
224714
Concept ID:
C1261473
Neoplastic Process
6.

Neoplasms, Bone Tissue

Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones. [from MeSH]

MedGen UID:
104905
Concept ID:
C0206639
Neoplastic Process
7.

Epithelioid Sarcoma

An aggressive malignant neoplasm of uncertain lineage, characterized by the presence of epithelioid cells forming nodular patterns. The nodules often undergo central necrosis, resulting in a pseudogranulomatous growth pattern. It usually occurs in young adults. The most common sites of involvement are the extremities (distal-type epithelioid sarcoma), and less frequently the pelvis, perineum, and genital organs (proximal-type epithelioid sarcoma). [from NCI]

MedGen UID:
104753
Concept ID:
C0205944
Neoplastic Process
8.

Connective and Soft Tissue Neoplasm

Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue. [from MeSH]

MedGen UID:
60224
Concept ID:
C0206765
Neoplastic Process
9.

Neoplasm of connective tissues

Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue. [from MeSH]

MedGen UID:
45035
Concept ID:
C0027656
Neoplastic Process
10.

Elderly person

A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available. [from MeSH]

MedGen UID:
7927
Concept ID:
C0001792
Finding
11.

Locally Recurrent Malignant Neoplasm

The reemergence of a malignant neoplasm after a period of remission at the site of the original tumor or adjacent to it. [from NCI]

MedGen UID:
458908
Concept ID:
C2986682
Neoplastic Process
12.

Stage II Soft Tissue Sarcoma

Stage II includes: IIA (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3); IIB (T2a, N0, M0, G2); (T2b, N0, M0, G2). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. G3: Grade 3. (AJCC 7th ed.) [from NCI]

MedGen UID:
277727
Concept ID:
C1336319
Neoplastic Process
13.

Stage III Bone Sarcoma

Stage III includes: T3, N0, M0, G3, G4. T3: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) [from NCI]

MedGen UID:
277707
Concept ID:
C1336243
Neoplastic Process
14.

Stage II Bone Sarcoma

Stage II includes: IIA (T1, N0, M0, G3, G4); IIB (T2, N0, M0, G3, G4). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) [from NCI]

MedGen UID:
233505
Concept ID:
C1336282
Neoplastic Process
15.

Stage III Adult Soft Tissue Sarcoma

MedGen UID:
124488
Concept ID:
C0278663
Neoplastic Process
16.

Stage II Adult Soft Tissue Sarcoma

Stage II tumor is defined as high-grade, superficial, and deep. G3, T1a, N0, M0/ G3, T1b, N0, M0/G3, T2a, N0, M0/ G4, T1a, N0, M0/ G4, T1b, N0, M0/ G4, T2a, N0, M0 (PDQ). [from NCI]

MedGen UID:
78856
Concept ID:
C0278662
Neoplastic Process
17.

Recurrent Adult Soft Tissue Sarcoma

MedGen UID:
75850
Concept ID:
C0278665
Neoplastic Process

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...